Dilini Gunatilake

Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB

Kavitha Gowrishankar, Dilini Gunatilake, Stuart Gallagher et al. · PLoS ONE · 2015 · 222 citations · Full text

Medicine, Immunology, Oncology +17

Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling

Anja Heinemann, Carleen Cullinane, Ricardo De Paoli‐Iseppi et al. · Oncotarget · 2015 · 87 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes

Jessamy Tiffen, Dilini Gunatilake, Stuart Gallagher et al. · Oncotarget · 2015 · 83 citations · Full text

Medicine, Cancer Biology, Oncology +17

Control of <scp>NF</scp>‐<scp>kB</scp> activity in human melanoma by bromodomain and extra‐terminal protein inhibitor <scp>I</scp>‐<scp>BET</scp>151

Stuart Gallagher, Branka Mijatov, Dilini Gunatilake et al. · Pigment Cell & Melanoma Research · 2014 · 82 citations

Life Sciences, Immunology, Oncology +17

Vascular senescence and leak are features of the early breakdown of the blood–brain barrier in Alzheimer’s disease models

Ka Ka Ting, Paul Coleman, Hani Jieun Kim et al. · GeroScience · 2023 · 66 citations · Full text

Life Sciences, Cell Biology, Neuroscience +17